Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Videos Gallery
  • Modular base editing for greater precision: The Pin-point platform for therapeutic genome engineering
presentation video hero
Video

Modular base editing for greater precision: The Pin-point platform for therapeutic genome engineering

Watch this short video overview presented by Amanda Haupt, base editing leader, Revvity at ASGCT to learn about:

  • How the editing system (not just the edit) can determine therapeutic outcomes
  • Why modular, decoupled systems enable precision tuning that fused architectures cannot
  • The key benefits of Revvity's Pin-point™ base editing platform
  • How it works and differs from other editing approaches
  • Supporting data for different applications

Pin-point™ base editing reagents are available for research use only and are not for diagnostic use or direct administration into humans or animals. The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.

Video thumbnail
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.

Scroll Icon